Acuis Daily is written by AI based on official sources. It may contain errors or omissions. Acuis Daily is for information purposes only. It is not legal or professional advice. Always check the official source before relying on an entry.
6 Nov 2026
/
EMA
/
Meeting
EMA committee recommends five veterinary medicines, including Scovella
At its 3–5 November meeting, EMA’s veterinary medicines committee recommended authorisation of Scovella, Credelio Quattro, Laverdia, Streptoporc and Nobivac PLUS DHPPi / Leptos. Scovella, for horses with Equine Metabolic Syndrome, is its first recommendation under the limited market regulatory framework. The committee also backed medicine updates and released pharmacovigilance terminology and residue-testing guidance for consultation.
Importance
Noteworthy
Lenses
Regulatory
Why it matters
The recommendations concern five new veterinary medicines, product information changes and technical consultations relevant to veterinary pharmaceutical developers.
Institution
EMA
Audience
Regulatory affairs teams
Tags
Health
Sectors
Pharmaceuticals
Dates
- 10 Dec 2026 · Joint antimicrobial consumption and resistance report publication
- 30 Apr 2027 · Consultation on veterinary residue-testing analytical methods closes
Source